Purpose The optimum dose and fractionation in radiation therapy of curative intent for non-
small cell lung cancer remains uncertain. We undertook a published data meta-analysis of …

At present, radiotherapy alone or in combination with chemotherapy offers the only chance
of cure of medically inoperable or locally advanced unresectable non-small cell lung cancer …

Chemotherapy and radiation therapy (RT) is the therapy of choice for patients with locally
advanced, inoperable non-small cell lung cancer (with an expected 4-year survival rate of …

PURPOSE: To review the published clinical data on non-small cell lung cancer treated with
radical radiotherapy to confirm a dose–response relationship as a basis for further dose …

Background The treatment results of radiotherapy in stage III non-small-cell lung cancer are
very poor. Several phase II studies showed that neoadjuvant chemotherapy followed by …

Purpose In lung cancer, randomized trials assessing hyperfractionated or accelerated
radiotherapy seem to yield conflicting results regarding the effects on overall (OS) or …

A systematic review of radiation therapy trials in several tumour types was performed by The
Swedish Council of Technology Assessment in Health Care (SBU). The procedures for …

Patients with unresectable stage III nonsmall cell lung cancer (T4, N3, or bulky N2) live
longer if they receive chemotherapy before or concurrent with thoracic irradiation …

Background: Survival of patients with locally advanced, unresectable (stage III), non-small-
cell lung cancer treated with radiotherapy is poor. Trials of the addition of chemotherapy to …

Background Concurrent chemoradiation is the standard of care in non-operable stage III non-
small-cell lung cancer (NSCLC). Data have suggested a benefit of dose escalation; …